Analysis Forecast COVID-19 Industry Impact Market Price Analysis Market Reports Market Size Market Study News

Esophageal Cancer Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

Esophageal cancer is a male-dominant aggressive malignancy and a leading cause of cancer-related mortality worldwide. Squamous cell carcinoma and adenocarcinoma are the two predominant histological subtypes with varying geographical and racial distribution. The risk of esophageal adenocarcinoma conferred by Barrett’s esophagus depends on factors such as genomic instability, race and gender of the patient. Esophageal cancer is the eighth most common cancer worldwide, and the sixth most common cause of cancer related deaths. Signs and symptoms of esophageal cancer include: Difficulty swallowing (dysphagia), Weight loss without trying,  Chest pain, pressure or burning, Worsening indigestion or heartburn, Coughing or hoarseness and many others.Esophageal cancer continues to be a predominantly fatal disease with only modest improvements in survival over the last three decades. Squamous cell cancer continues to be the most common histological subtype globally and accounts for most deaths from esophageal cancer. In the Western world, the incidence of esophageal adenocarcinoma has superseded that of esophageal squamous cell carcinoma, with most cases occurring in Caucasian males. 

Get FREE sample copy at:


Esophageal Cancer Market Analysis

DelveInsight’s “Esophageal Cancer Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Esophageal Cancer, historical and forecasted epidemiology as well as the Esophageal Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Esophageal Cancer market report also covers emerging drugs, current treatment practices, Esophageal Cancer market share of the individual therapies, current and forecasted Esophageal Cancer Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Esophageal Cancer treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 


Esophageal Cancer Market Key Facts

According to the NORD, approximately 17,000 people are diagnosed with esophageal cancer in the United States each year.

Squamous cell carcinoma and adenocarcinoma account for about 95% of people with esophageal cancer in the United States.

Esophageal cancer is more common among men than among women. The lifetime risk of esophageal cancer in the United States is about 1 in 125 in men and about 1 in 417 in women.


Key Benefits of Esophageal Cancer Market Report

  • Esophageal Cancer market report provides an in-depth analysis of Esophageal Cancer Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
  • The Esophageal Cancer market report will help in developing business strategies by understanding the Esophageal Cancer Market trends & developments, key players and future market competition that will shape and drive the Esophageal Cancer market in the upcoming years.
  • The Esophageal Cancer market report covers Esophageal Cancer current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
  • The report provides a detailed assessment of the Esophageal Cancer market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 


Esophageal Cancer Market
Extensive R&D activities by academias and companies such as Innovent Biosciences, Lee pharmaceutical and others shall fuel the growth of the market during the forecast period, i.e., 2020–2030.
The Esophageal cancer market size shall grow during the forecast period owing to the already launched therapies. The market size is expected to increase at a significant CAGR during the study period.

The Esophageal Cancer market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Esophageal Cancer market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Esophageal Cancer market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 


Esophageal Cancer Epidemiology

The Esophageal Cancer epidemiology section covers insights about historical and current Esophageal Cancer patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  


Esophageal Cancer Drugs Uptake and Key Market Players

The Esophageal Cancer Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Esophageal Cancer market or expected to get launched in the market during the study period. The analysis covers Esophageal Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The dynamics of the Esophageal Cancer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world. The launch of several emerging therapies is expected during the forecast period of 2020-2030.

The pipeline of Esophageal Cancer is quite robust with several products available in the developmental stage. There are several key players involved in the development of promising products for Esophageal Cancer. Some of the key players in the Esophageal Cancer market includes:
Shanghai Junshi
Jiangsu Hengrui Medicine
Sunshine Lake Pharma
Innovent Biosciences
Lee Pharmaceutical
And many others.

Drugs Covered
ZKAB 001
And many others


Get FREE sample copy at:


Table of Content

  1. Key Insights
  2. Executive Summary 
  3. Esophageal Cancer Competitive Intelligence Analysis
  4. Esophageal Cancer Market Overview at a Glance
  5. Esophageal Cancer Disease Background and Overview
  6. Esophageal Cancer Patient Journey
  7. Esophageal Cancer Epidemiology and Patient Population
  8. Esophageal Cancer Treatment Algorithm, Current Treatment, and Medical Practices
  9. Esophageal Cancer Unmet Needs
  10. Key Endpoints of Esophageal Cancer Treatment
  11. Esophageal Cancer Marketed Products
  12. Esophageal Cancer Emerging Therapies
  13. Esophageal Cancer Seven Major Market Analysis
  14. Attribute Analysis
  15. Esophageal Cancer Market Outlook (7 major markets)
  16. Esophageal Cancer Access and Reimbursement Overview
  17. KOL Views on the Esophageal Cancer Market.
  18. Esophageal Cancer Market Drivers
  19. Esophageal Cancer Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer


Related Reports

Esophageal Cancer Epidemiology Forecast to 2030

DelveInsight’s Esophageal Cancer – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Esophageal Cancer in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Esophageal Cancer Pipeline Insights, 2020

Esophageal Cancer Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Esophageal Cancer market.

Esophageal Cancer – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

Esophageal Cancer – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 ” report by DelveInsight offers comprehensive insights on marketed and Phase III products for Esophageal Cancer.


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.


Contact us:
Shruti Thakur
[email protected]
LinkedIn | Facebook | Twitter
Get Free Sample Copy of Report at: